1-4 of 4
Franz X Gruber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects of Dasatinib and Interferon-α Combination Treatment on the Immune System in CML

Mette Ilander, PhD, Hanna Lähteenmäki, MSc, Ulla Olsson-Stromberg, MD PhD, Jesper Stentoft, MD PhD, Johan Richter, MD, Perttu Koskenvesa, MD, Martin Höglund, MD PhD, Arta Dreimane, MD PhD, Kimmo Porkka, MD PhD, Tobias Gedde-Dahl, Björn T. Gjertsen, Franz X. Gruber, Leif Stenke, MD PhD, Kristina Myhr-Eriksson, MD, Berit Markevärn, MD, Anna Lubking, MD, Hanne Vestergaard, MD PhD, Lene Udby, MD, Ole Weis Bjerrum, MD, Henrik Hjorth-Hansen, MD PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2016) 128 (22): 627.
https://doi.org/10.1182/blood.V128.22.627.627
Published: 2016
Journal Articles

Safety and Efficacy of Addition of Pegylated Interferon alpha2b to Standard Dose Dasatinib in Newly Diagnosed Chronic Phase CML Patients

Henrik Hjorth-Hansen, MD PhD, Jesper Stentoft, Johan Richter, MD PhD, Perttu Koskenvesa, MD, Arta Dreimane, MD, Kimmo Porkka, MD PhD, Tobias Gedde-Dahl, MDPhD, Bjorn Gjertsen, MD PhD, Franz X. Gruber, MDPhD, Martin Hoglund, MD PhD, Anna Lubking, MD, Kristina Myhr-Eriksson, MD, Berit Markevärn, Hanne Vestergaard, MDPhD, Ole Weis Bjerrum, MDPhD, Leif Stenke, MDPhD, Satu Mustjoki, MD PhD, Ulla Stromberg, MDPhD
Journal: Blood
Blood (2015) 126 (23): 477.
https://doi.org/10.1182/blood.V126.23.477.477
Published: 2015
Journal Articles

Kinetics of BCR-ABL Mutant Clones Determines Resistance in CML on Second Generation TKI Treatment.

Franz X Gruber, MD, Thomas Ernst, MD, Jaqueline Maier, PhD, Martin C. Müller, MD, Ingvild Mikkola, PhD, Kimmo Porkka, MD, PhD, Dietger Niederwieser, Andreas Hochhaus, MD, Thoralf Lange, MD
Journal: Blood
Blood (2008) 112 (11): 2127.
https://doi.org/10.1182/blood.V112.11.2127.2127
Published: 2008
Journal Articles

Extracellular Signal-Regulated Protein Kinase 5 Mediates Resistance of Human Chronic Myeloid Leukemia K562 Cells to Imatinib.

Mikhail A. Sovershaev, MD, MSc, Elena M. Egorina, M.D., Franz X. Gruber, M.D., Geir Bjørkøy, Ph.D., Terje Johansen, Ph.D
Journal: Blood
Blood (2006) 108 (11): 2131.
https://doi.org/10.1182/blood.V108.11.2131.2131
Published: 2006